The transmembrane protein LRIG2 increases tumor progression in skin carcinogenesis
Over the last few decades, the number of cases of non‐melanoma skin cancer (NMSC) has risen to over 3 million cases every year worldwide. Members of the ERBB receptor family are important regulators of skin development and homeostasis and, when dysregulated, contribute to skin pathogenesis. In this...
Main Authors: | Christine Hoesl, Thomas Fröhlich, Jennifer E. Hundt, Hermann Kneitz, Matthias Goebeler, Ronald Wolf, Marlon R. Schneider, Maik Dahlhoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-11-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12579 |
Similar Items
-
The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis
by: Christine Hoesl, et al.
Published: (2021-08-01) -
Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma
by: Thomasson Marcus, et al.
Published: (2012-05-01) -
Studies of LRIG1 and the ERBB receptor family in breast and colorectal cancer
by: Ljuslinder, Ingrid
Published: (2009) -
The importance og LRIG1 in lung cancer
by: Kvarnbrink, Samuel
Published: (2012) -
The LRIG-family: identification of novel regulators of ErbB signaling with clinical implications in astrocytoma
by: Nilsson, Jonas
Published: (2006)